CLEC2D (ZM-008 Biosimilar) Recombinant Monoclonal Antibody
-
貨號(hào):CSB-RA883401MB1HU
-
規(guī)格:¥83486
-
其他:
產(chǎn)品詳情
-
產(chǎn)品描述:CLEC2D (ZM-008 Biosimilar Antibody)重組單克隆抗體是一種用于科研領(lǐng)域的生物試劑,其設(shè)計(jì)基于CLEC2D靶點(diǎn)的特異性結(jié)合特性。該抗體通過(guò)重組DNA技術(shù)在工程化細(xì)胞中表達(dá),經(jīng)過(guò)嚴(yán)格的純化工藝獲得高純度、高活性的單克隆抗體產(chǎn)品。作為科研工具,它可用于免疫學(xué)、細(xì)胞生物學(xué)及相關(guān)領(lǐng)域的基礎(chǔ)研究,助力探索CLEC2D分子在生理和病理過(guò)程中的功能作用。 該抗體具有高特異性和親和力,能夠精準(zhǔn)識(shí)別并結(jié)合CLEC2D蛋白,適用于等多種實(shí)驗(yàn)技術(shù)。其重組表達(dá)體系確保了批次間的穩(wěn)定性和一致性,為實(shí)驗(yàn)結(jié)果的可靠性提供保障。研究人員可利用該抗體深入研究CLEC2D介導(dǎo)的信號(hào)通路、受體-配體相互作用及相關(guān)疾病的分子機(jī)制,為免疫學(xué)基礎(chǔ)理論研究和潛在治療靶點(diǎn)發(fā)現(xiàn)提供有力支持。 CLEC2D (ZM-008 Biosimilar Antibody)重組單克隆抗體的開(kāi)發(fā)嚴(yán)格遵循科研試劑的質(zhì)量標(biāo)準(zhǔn),經(jīng)過(guò)全面的性能驗(yàn)證,包括抗體純度、特異性結(jié)合能力及生物活性檢測(cè)。作為科研用試劑,它為揭示CLEC2D在免疫調(diào)節(jié)、炎癥反應(yīng)等生理過(guò)程中的作用提供了重要工具,有助于推動(dòng)相關(guān)領(lǐng)域的研究進(jìn)展。
-
Uniprot No.:
-
基因名:
-
別名:ZM008 research-grade biosimilar; ZM-008 research-grade biosimilar ;CLEC2D antibody; CLAX antibody; LLT1 antibody; OCIL antibody; C-type lectin domain family 2 member D antibody; Lectin-like NK cell receptor antibody; Lectin-like transcript 1 antibody; LLT-1 antibody; Osteoclast inhibitory lectin antibody
-
反應(yīng)種屬:Human
-
免疫原:Recombinant Human CLEC2D protein
-
免疫原種屬:Homo sapiens (Human)
-
標(biāo)記方式:Non-conjugated
-
克隆類型:Monoclonal
-
濃度:It differs from different batches. Please contact us to confirm it.
-
保存緩沖液:0.01M PBS,pH7.4
-
產(chǎn)品提供形式:Liquid
-
應(yīng)用說(shuō)明:Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity?> 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method. -
儲(chǔ)存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期:3-4 weeks
-
用途:It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.
相關(guān)產(chǎn)品
靶點(diǎn)詳情
-
功能:Receptor for KLRB1 that protects target cells against natural killer cell-mediated lysis. Inhibits osteoclast formation. Inhibits bone resorption. Modulates the release of interferon-gamma. Binds high molecular weight sulfated glycosaminoglycans.
-
基因功能參考文獻(xiàn):
- These results show that susceptibility of normal articular chondrocytes to lysis by NK cells is modulated by NKR-P1A/LLT1 interactions. Thus, NKR-P1A/LLT1 interaction might provide some novel target for therapeutic interventions in the course of pathological cartilage injury. PMID: 29212911
- Blocking LLT1-NKRP1A interaction will make prostate cancer cells susceptible to killing by NK cells, suggesting a therapeutic option for treatment of prostate cancer. PMID: 27626681
- these data suggest that LLT1-CD161 interactions play a novel and important role in B cell maturation within the Germinal center in humans. PMID: 26829983
- In RA joints, LLT1 is expressed by cells of the monocyte/macrophage lineage. PMID: 26147876
- The hexamer of glycosylated LLT1 consists of three classical dimers. The hexameric packing may indicate a possible mode of interaction of C-type lectin-like proteins in the glycosylated form. PMID: 25760607
- One polymorphism in LLT1 was found to be associated with our Crohn's Disease population (P<0.034).Our Ulcerative Colitis cohort was not associated with the variation in LLT1 (P=0.33) PMID: 22664939
- LLT1 and CD161 have roles in modulating immune responses to pathogens; and interferon-gamma contributes to modulate immune responses PMID: 21930700
- Molecular basis for LLT1 protein recognition by human CD161 protein (NKRP1A/KLRB1). PMID: 21572041
- Data show that only CLEC2D isoform 1 (LLT1) is expressed on the cell surface. PMID: 20843815
- LLT1 used Src-PTK, p38 and ERK signalling pathways, but not PKC, PI3K or calcineurin pathways, to increase production of IFN-gamma by human natural killer cells. PMID: 20415786
- LLT1 induces Interferon Type II production by natural killer cells. PMID: 15104121
- Data show that osteoclast inhibitory lectin (OCIL) binds a range of physiologically important glycosaminoglycans, and this property may modulate OCIL actions upon other cells [OCIL]. PMID: 15123656
- Engagement of CD161 on NK cells with LLT1 expressed on target cells inhibited NK cell-mediated cytotoxicity and IFN-gamma secretion. LLT1/CD161 interaction in the presence of a TCR signal enhanced IFN-gamma production by T cells PMID: 16339512
- LLT1 on target cells can inhibit NK cytotoxicity via interactions with CD161. LLT1 activates NFAT-GFP reporter cells expressing a CD3zeta-CD161 chimeric receptor; reciprocally, reporter cells with a CD3zeta-LLT1 chimeric receptor are stimulated by CD161 PMID: 16339513
- Expression of LLT1 on activated dendritic cells and B cells suggests that it might regulate the cross-talk between NK cells and APCs PMID: 18453569
- Women with a lysine (GG genotype) at position 19 of the OCIL protein displayed lower bone mineral density at femoral neck and at lumbar spine sites than women having an asparagine residue. PMID: 18465072
顯示更多
收起更多
-
亞細(xì)胞定位:Cell membrane; Single-pass type II membrane protein.; [Isoform 2]: Endoplasmic reticulum.; [Isoform 4]: Endoplasmic reticulum.
-
組織特異性:Detected in peripheral blood leukocytes, osteoblasts, lymph node, thymus and spleen. Isoform 1, isoform 2 and isoform 4 are expressed in T- and B-lymphocytes, and at lower levels in NK cells. They are also expressed in B-cell lines and LPS-matured monocyt
-
數(shù)據(jù)庫(kù)鏈接:
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-















